Novonesis (Novozymes) B/ DK0060336014 /
| 2024-07-24 4:54:50 PM | Chg. +11.40 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 431.80DKK | +2.71% | 42,081 Turnover: 18.05 mill. |
-Bid Size: - | -Ask Size: - | 119.77 bill.DKK | 0.97% | 39.55 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 10.92 DKK | -17.83% |
| EPS Diluted: | - DKK | -17.51% |
| Revenues per Share: | 64.54 DKK | 2.49% |
| Book Value per Share: | 50.40 DKK | 1.54% |
| Cash Flow per Share: | 14.97 DKK | 4.17% |
| Dividend per Share: | 4.20 DKK | -30.00% |
| Total | in mill. | |
| Revenues: | 17,899.00 DKK | 1.97% |
| Net Income: | 3,024.00 DKK | -17.96% |
| Operating Cash Flow: | 4,152.00 DKK | - |
| Cash and Cash Equivalents: | 1,116.00 DKK | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 39.55 | 33.98 |
| P/S Ratio: | 6.69 | 5.75 |
| P/BV ratio: | 8.57 | 7.36 |
| P/CF Ratio: | 28.85 | 24.79 |
| PEG: | -2.22 | -1.91 |
| Earnings Yield: | 2.53% | 2.94% |
| Dividend Yield: | 0.97% | 1.13% |
| Market Capitalization | ||
| Market Capitalization: | 119.77 bill. DKK | 102.91 bill. DKK |
| Free Float Market Cap.: | - DKK | - DKK |
| Market Cap. / Employee: | 17.73 mill. DKK | 15.23 mill. DKK |
| Shares Outstanding: | 277.32 mill. | |
Profitability
| Gross Profit Margin: | 54.32% |
| EBIT Margin: | 22.21% |
| Net Profit Margin: | 16.89% |
| Return on Equity: | 21.63% |
| Return on Assets: | 10.65% |
Financial Strength
| Liquidity I / Cash Ratio: | 15.37% |
| Liquidity II / Quick Ratio: | 66.35% |
| Liquidity III / Current Ratio: | 130.29% |
| Debt / Equity Ratio: | 103.11% |
| Dynam. Debt / Equity Ratio: | 347.13% |
Efficiency
| Employees: | 6,756 |
| Personal Expenses / Employee: | - DKK |
| Revenues / Employee: | 2,649,348.73 DKK |
| Net Income / Employee: | 447,602.13 DKK |
| Total Assets / Employee: | 4,202,338.66 DKK |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | DKK |
